Farallon Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
2019
Q1
$14.9M Sell
2018
Q4
$18M Buy
2017
Q3
Sell
2017
Q2
$57.1M Buy
2017
Q1
$5.09M Buy
2014
Q4
Sell
2014
Q3
$10.2M Hold
2014
Q2
$9.32M Buy